Eric C. M. Van Gorp

8.2k total citations · 2 hit papers
139 papers, 4.2k citations indexed

About

Eric C. M. Van Gorp is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Eric C. M. Van Gorp has authored 139 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Infectious Diseases, 50 papers in Epidemiology and 47 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Eric C. M. Van Gorp's work include Viral Infections and Vectors (41 papers), Mosquito-borne diseases and control (40 papers) and HIV Research and Treatment (17 papers). Eric C. M. Van Gorp is often cited by papers focused on Viral Infections and Vectors (41 papers), Mosquito-borne diseases and control (40 papers) and HIV Research and Treatment (17 papers). Eric C. M. Van Gorp collaborates with scholars based in Netherlands, Indonesia and United States. Eric C. M. Van Gorp's co-authors include Marco Goeijenbier, Marion Koopmans, Martijn D. de Kruif, Albert D. M. E. Osterhaus, Maarten Limper, Matthijs P. Raadsen, Jiri F. P. Wagenaar, Henrik Endeman, Dees P. M. Brandjes and Bart L. Haagmans and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Eric C. M. Van Gorp

135 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phenotype and kinetics of SARS-CoV-2–specific T cells in COVID-19 patients with acute respiratory distress syndrome

2020 587 citations Daniela Weiskopf, Katharina S. Schmitz et al. Science Immunology profile →
Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals

2022 147 citations Leanne P. M. van Leeuwen, Katharina S. Schmitz et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric C. M. Van Gorp Netherlands	36	2.4k	1.2k	964	516	494	139	4.2k
David Baud Switzerland	40	1.8k 0.8×	2.3k 1.9×	1.3k 1.4×	688 1.3×	664 1.3×	206	6.6k
Carlos Brites Brazil	34	1.9k 0.8×	592 0.5×	925 1.0×	1.1k 2.1×	361 0.7×	244	4.3k
Pierre Delobel France	33	1.7k 0.7×	625 0.5×	751 0.8×	497 1.0×	307 0.6×	127	2.9k
David Nadal Switzerland	43	1.6k 0.7×	711 0.6×	2.1k 2.2×	1.2k 2.4×	485 1.0×	220	5.9k
Nicola P. Klein United States	52	2.8k 1.1×	469 0.4×	5.5k 5.7×	715 1.4×	711 1.4×	295	10.0k
Stephen B. Greenberg United States	40	1.6k 0.7×	780 0.7×	2.9k 3.0×	722 1.4×	319 0.6×	124	6.0k
Tim Spelman Australia	40	1.3k 0.5×	425 0.4×	1.4k 1.5×	514 1.0×	302 0.6×	222	4.7k
Thomas Benfield Denmark	46	3.4k 1.4×	677 0.6×	4.2k 4.3×	909 1.8×	773 1.6×	370	8.6k
Laurence Baril France	28	1.0k 0.4×	740 0.6×	687 0.7×	209 0.4×	170 0.3×	74	2.5k
Odile Launay France	39	2.6k 1.1×	365 0.3×	3.3k 3.5×	810 1.6×	406 0.8×	274	6.0k

Countries citing papers authored by Eric C. M. Van Gorp

Since Specialization

Citations

This map shows the geographic impact of Eric C. M. Van Gorp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric C. M. Van Gorp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric C. M. Van Gorp more than expected).

Fields of papers citing papers by Eric C. M. Van Gorp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric C. M. Van Gorp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric C. M. Van Gorp. The network helps show where Eric C. M. Van Gorp may publish in the future.

Co-authorship network of co-authors of Eric C. M. Van Gorp

This figure shows the co-authorship network connecting the top 25 collaborators of Eric C. M. Van Gorp. A scholar is included among the top collaborators of Eric C. M. Van Gorp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric C. M. Van Gorp. Eric C. M. Van Gorp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boyd, Anders, Jilske Huijben, Lieuwe D. J. Bos, et al.. (2025). Inflammatory Biomarkers Demonstrate Predictive Capacity for Mortality in COVID-19-Related ARDS Patients Receiving High-Dose Corticosteroids: A Longitudinal Analysis. Journal of Inflammation Research. Volume 18. 2395–2408. 1 indexed citations

Gietema, Hester A., Bas C. T. van Bussel, Matthijs F.M. van Oosterhout, et al.. (2025). In situ pulmonary thrombosis and pulmonary embolus are distinct thrombotic phenotypes in critically ill patients with COVID-19 Acute Respiratory Distress Syndrome. Journal of Thrombosis and Haemostasis. 24(2). 662–671.

Leeuwen, Leanne P. M. van, Thomas Langerak, M Hakim, et al.. (2024). The role of antibody-dependent enhancement in dengue vaccination. Tropical Diseases Travel Medicine and Vaccines. 10(1). 14 indexed citations

Goeijenbier, Marco, Dennis Souverein, Michael Nagel, et al.. (2024). Post COVID-19 Pandemic Increased Detection of Mycoplasma Pneumoniae in Adults Admitted to the Intensive Care. Journal of Clinical Medicine. 13(12). 3443–3443. 2 indexed citations

Liesenfeld, Oliver, Jilske Huijben, Virgil A. S. H. Dalm, et al.. (2023). A Transcriptomic Severity Classifier IMX-SEV-3b to Predict Mortality in Intensive Care Unit Patients with COVID-19: A Prospective Observational Pilot Study. Journal of Clinical Medicine. 12(19). 6197–6197. 1 indexed citations

Rokx, Casper, Els van Nood, Eric C. M. Van Gorp, et al.. (2023). Levels of Fibrinogen Variants Are Altered in Severe COVID-19. SHILAP Revista de lepidopterología. 7(3). e217–e225. 5 indexed citations

Slotman, Johan A., Coen Maas, Hannelore I. Bax, et al.. (2022). Altered fibrin network structure and fibrinolysis in intensive care unit patients with COVID‐19, not entirely explaining the increased risk of thrombosis. Journal of Thrombosis and Haemostasis. 20(6). 1412–1420. 10 indexed citations

Langerak, Thomas, Michelle Broekhuizen, Peter‐Paul A. Unger, et al.. (2022). Transplacental Zika virus transmission in ex vivo perfused human placentas. PLoS neglected tropical diseases. 16(4). e0010359–e0010359. 12 indexed citations

Ouwendijk, Werner J. D., Matthijs P. Raadsen, Jeroen J. A. van Kampen, et al.. (2021). High Levels of Neutrophil Extracellular Traps Persist in the Lower Respiratory Tract of Critically Ill Patients With Coronavirus Disease 2019. The Journal of Infectious Diseases. 223(9). 1512–1521. 49 indexed citations

10.

Weiskopf, Daniela, Katharina S. Schmitz, Matthijs P. Raadsen, et al.. (2020). Phenotype and kinetics of SARS-CoV-2–specific T cells in COVID-19 patients with acute respiratory distress syndrome. Science Immunology. 5(48). 587 indexed citations breakdown →

11.

Langerak, Thomas, et al.. (2019). The possible role of cross-reactive dengue virus antibodies in Zika virus pathogenesis. PLoS Pathogens. 15(4). e1007640–e1007640. 69 indexed citations

12.

Leal, Lorna, Jozefien Buyze, Pieter Pannus, et al.. (2019). Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMix. Vaccines. 7(4). 209–209. 30 indexed citations

13.

Landis, R. Clive, George Janossy, Patrice Joseph, et al.. (2018). Shifting the HIV Paradigm from Care to Cure: Proceedings from the Caribbean Expert Summit in Barbados, August 2017. AIDS Research and Human Retroviruses. 34(7). 561–569. 4 indexed citations

14.

Goeijenbier, Marco, Eric C. M. Van Gorp, Barry Rockx, et al.. (2015). Seoul hantavirus in brown rats in the Netherlands: implications for physicians--Epidemiology, clinical aspects, treatment and diagnostics.. PubMed. 73(4). 155–60. 19 indexed citations

15.

Goeijenbier, Marco, Georgina I. Aron, Åke Lundkvist, et al.. (2015). Emerging Viruses in the Republic of Suriname: Retrospective and Prospective Study into Chikungunya Circulation and Suspicion of Human Hantavirus Infections, 2008–2012 and 2014. Vector-Borne and Zoonotic Diseases. 15(10). 611–618. 8 indexed citations

16.

Cleton, Natalie, Chantal Reusken, & Eric C. M. Van Gorp. (2014). [The chikungunya epidemic in the Caribbean: implications for travellers and physicians].. PubMed. 158. A7918–A7918. 2 indexed citations

17.

Weg, Cornelia A. M. van de, Cláudio Mendes Pannuti, Henk‐Jan van den Ham, et al.. (2014). Serum angiopoietin-2 and soluble VEGF receptor 2 are surrogate markers for plasma leakage in patients with acute dengue virus infection. Journal of Clinical Virology. 60(4). 328–335. 51 indexed citations

18.

Goris, Marga G. A., Masja Straetemans, Sandra Alba, et al.. (2013). Towards the Burden of Human Leptospirosis: Duration of Acute Illness and Occurrence of Post-Leptospirosis Symptoms of Patients in The Netherlands. PLoS ONE. 8(10). e76549–e76549. 39 indexed citations

19.

Maat, Monique M. R. de, Alwin D. R. Huitema, Jan W. Mulder, et al.. (2002). Population pharmacokinetics of nevirapine in an unselected cohort of HIV‐1‐infected individuals. British Journal of Clinical Pharmacology. 54(4). 378–385. 80 indexed citations

20.

Gorp, Eric C. M. Van, Catharina Suharti, Albert T.A. Mairuhu, et al.. (2002). Changes in the Plasma Lipid Profile as a Potential Predictor of Clinical Outcome in Dengue Hemorrhagic Fever. Clinical Infectious Diseases. 34(8). 1150–1153. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact